Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S6W-28615 · Session 6

What evidence it has to support its current policy that 12-week rehabilitation programmes are suitable, and what its response is to studies…

Answered Asked by Monica Lennon Lab Lodged 16 Jul 2024

The question

To ask the Scottish Government what evidence it has to support its current policy that 12-week rehabilitation programmes are suitable, and what its response is to studies showing that longer treatment durations can lead to better outcomes.

The answer

Answered by Christina McKelvie on 9 Aug 2024 · 24 days after it was lodged, on time

The Residential Rehabilitation Development Working Group’s 2020 report noted that there was some evidence that rehabilitation programmes of 12 weeks had led to more successful treatment outcomes. However, the recommendations were also clear that further research was required on the length of rehabilitation programmes and their correlation to outcomes across Scotland.
The Scottish Government’s current position is that all placements for residential rehabilitation should be assessed on an individual needs basis, and it is ultimately for professionals and clinicians to make the decision locally as to whether a shorter or longer programme is effective for the individuals involved.
As part of our work on developing the residential rehabilitation evidence base, the Scottish Government published a literature review in 2022 which looked at existing evidence and research gaps. As noted in Page 14, residential rehabilitation encompasses a diverse range of treatment models, and there is no one programme which has proven to produce routinely better outcomes for individuals.
The Scottish Government and Public Health Scotland have worked collaboratively with stakeholders to establish a core minimum dataset to support the monitoring and evaluation of residential rehabilitation. It is expected that the first extracts will be published in December, where a greater level of insight and data will be available, including average treatment length and associated outcomes, as the dataset continues to develop and mature.

In the Official Report

No contribution in the Official Report cites S6W-28615 by reference.